Professional Documents
Culture Documents
Parkinson's disease
• Motor features
– Resting tremor
– Bradykinesia
– Rigidity
– Postural instability
• ~ 500.000 patients in US
• 1 % of > 50 yo.
• 2nd most common MD
• Lifetime risk
– 2 % for men, 1.3 % for women
• Projected increase
– Patient numbers will double to
8-9 million worldwide in 2030
D1
D2
• Intraneuronal eosinophilic
inclusion bodies (Lewy)
– Brainstem
– Diffuse distribution in cortex
– Staining + for alpha-synuclein
• Reactive gliosis
Lewy body and Lewy neurites
-SYNUCLEINE +
• 2003 Braak et al.:
• Staging of PD pathology
– Allows to understand
presymptomatic disease and
non motor manifestations
• PARK 1-13
• 5 autosomal dominant:
– PARK 1 (=4), 4 is the triplication form of PARK1
– 3, 5, 8, 13
• 4 recessive:
– PARK 2,6,7,9
• 1 X-linked:
– PARK 12
• Penetrance low, 33 %
• Severity depends on gene dosage,
– patients with duplication resemble “idiopathic” PD more than triplication
cases
• homozygous forms of this mutation exist, but are not more severe than
heterozygous
• Localization:
– ubiquitous expression
– cytosolic, may translocate to mitochondria with pH changes
• Function:
– chaperone-like activity,
– intracellular sensor of oxidative stress
– regulates D2 receptor signaling
– Direct action as antioxidant ?
• DJ-1 mutants
– show increased vulnerability to energy metabolism changes
• Inhibition of complex I:
– Depletion of ATP, impairment of dependent processes
– Generation of free radicals causing oxidative stress
2. Heterozygous mutations
- may be associated with PET, MRI, ultrasound changes
- Subtle motor signs in “asymptomatic” carriers
- Unclear if these are developmental changes, early disease
markers or adaptive